Core Hypothesis

Aging-associated loss of cholinergic myenteric neurons isn't just a passive result of oxidative stress; it's driven by a self-amplifying cycle where nitrated α-synuclein (N-Syn) directly inhibits mitochondrial complex I, boosting superoxide output. The excess ROS further nitrates α-synuclein, raising N-Syn load. This mitochondrial-nitrative stress hits cholinergic cells harder because they depend on aerobic metabolism for acetylcholine synthesis and have weaker baseline antioxidant defenses than nitrergic neurons. At the same time, age-related drop in vagal cholinergic output weakens the cholinergic anti-inflammatory pathway, letting M1 macrophages multiply and release cytokines (TNF-alpha, IL-1beta) that suppress GDNF signaling and worsen neuronal vulnerability.

Testable Predictions

1. Mitochondrial complex I activity in isolated cholinergic myenteric neurons from aged (>24 mo) mice will be significantly lower than in nitrergic neurons and will correlate inversely with N-Syn immunoreactivity (6).
2. Restoring complex I function—either pharmacologically (e.g., low-dose NADPH oxidase inhibitor) or genetically (neuronal NDUFS4 overexpression)—will cut ROS, lower N-Syn formation, and preserve cholinergic neuron numbers in aged colon without affecting nitrergic populations.
3. Performing a subdiaphragmatic vagotomy in young adult mice will speed up the N-Syn/mitochondrial dysfunction loop, reproducing the aged phenotype, whereas chronic vagal stimulation in aged mice will dampen M1 macrophage infiltration (4) and slow neuronal loss.
4. Combining a mitochondria-targeted antioxidant (MitoQ) with vagal neuromodulation will produce a synergistic rescue of cholinergic neuron density and improve colonic transit measured by 3D-Transit capsules (9).

Experimental Approach

• Use retrograde labeling to isolate cholinergic (ChAT-positive) and nitrergic (nNOS-positive) myenteric neurons from young (3 mo) and aged mice.
• Measure complex I enzymatic activity, mitochondrial ROS (MitoSOX), and N-Syn levels via immunoblot and immunofluorescence.
• Deploy AAV-mediated neuronal overexpression of NDUFS4 or administer MitoQ; assess neuron counts (Neun/ChAT) and colonic motility.
• Perform subdiaphragmatic vagotomy or vagal nerve stimulation; quantify M1 macrophages (CD86+ iNOS+) and GDNF levels.
• Correlate findings with human tissue from organ donors (young vs >65 y) using the same markers.

Falsifiability

If aged cholinergic myenteric neurons show no deficit in complex I activity, or if rescuing complex I fails to lower N-Syn or prevent neuron loss despite reduced ROS, the hypothesis would be refuted. Likewise, if vagal manipulation doesn't alter macrophage phenotype or neuronal survival independent of mitochondrial changes, the proposed feed-forward loop would be insufficient to explain age-related neurodegeneration.